絞り込み

16555

広告

Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.

著者 Arabi M , Alsaadi T , Nasreddine W , Al-Hashel J , Dirani M , Beydoun A
Epilepsy Behav.2018 May 17 ; 84():118-121.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (33view , 0users)

Full Text Sources

Lacosamide (LCM) was recently introduced in the Middle East. The aim of this study was to evaluate the safety, tolerability, and efficacy of LCM in patients with focal onset seizures and determine if our results are comparable with those derived from Western countries.
PMID: 29778846 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード